About this trial
A comparison of 3 Tesla MRI to 7 Tesla MRI for Evaluation of Prostate Suspicious Lesions.
Assess the added diagnostic value of ultra-high-field (7T) MRI over the current clinical standard (3T MRI) in detecting and characterizing suspicious prostate lesions. Evaluate whether dynamic deuterated glucose-enhanced imaging at 7T can offer improved contrast without the use of gadolinium-based agents.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
male patients referred for clinical 3T prostate MRI at Shamir Medical Center
male patients who consent to undergo an additional 7T scan at the Weizmann Institute.
Disqualifiers
Contraindications to MRI (e.g., non-compatible implants, pacemakers, severe claustrophobia)
diabetes mellitus
glucose intolerance
hyperglycemia
Trial design
Single group
Treatments tested in this trial
3T and 7T MRI scans
Diagnostic testImaging protocols will include multiparametric sequences at both field strengths, with the addition of high-resolution anatomical and optional dynamic glucose-enhanced imaging at 7T.
Treatment groups
Trial outcomes
Primary outcomes
ROC analysis of diagnostic performance: 3T versus 7T MRI
ROC analysis (Receiver Operating Characteristic analysis) - A statistical method used to evaluate and compare diagnostic accuracy. It examines how well a test distinguishes between diseased and non-diseased cases across different thresholds.
Sensitivity and Specificity of diagnostic performance: 3T versus 7T MRI
Sensitivity - The ability of the MRI to correctly identify patients who truly have disease (true positive rate). High sensitivity means fewer missed cases. Specificity - The ability of the MRI to correctly identify patients who do not have disease (true negative rate). High specificity means fewer false alarms or false positives.
Lesion conspicuity of diagnostic performance: 3T versus 7T MRI
How clearly and visibly an abnormal lesion can be seen on MRI images compared with surrounding tissue. Higher conspicuity generally makes lesions easier to detect and characterize.
PI-RADS classification - The Prostate Imaging Reporting and Data System: 3T versus 7T MRI
a standardized scoring system used in prostate MRI to estimate the likelihood of clinically significant prostate cancer. Scores range from 1 (very low likelihood) to 5 (very high likelihood).
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: